KR940009280B1 - 항생물질 A 40926 복합체 및 순수한 그의 인자 PA, PB, A, B 및 Bo의 제조방법 - Google Patents

항생물질 A 40926 복합체 및 순수한 그의 인자 PA, PB, A, B 및 Bo의 제조방법 Download PDF

Info

Publication number
KR940009280B1
KR940009280B1 KR1019850007474A KR850007474A KR940009280B1 KR 940009280 B1 KR940009280 B1 KR 940009280B1 KR 1019850007474 A KR1019850007474 A KR 1019850007474A KR 850007474 A KR850007474 A KR 850007474A KR 940009280 B1 KR940009280 B1 KR 940009280B1
Authority
KR
South Korea
Prior art keywords
antibiotic
factor
eluent
ppm
teicoplanin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
KR1019850007474A
Other languages
English (en)
Korean (ko)
Other versions
KR860003342A (ko
Inventor
셀바 엔리코
가스탈도 루치아노
베레타 그라지아
보르기 안젤로
피. 골드스테인 베드
아리올리 비토리오
카싸니 지오반니
파렌티 프란체스코
Original Assignee
그루포 레페티트 에스.피.에이
레나로 스가르비
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 그루포 레페티트 에스.피.에이, 레나로 스가르비 filed Critical 그루포 레페티트 에스.피.에이
Publication of KR860003342A publication Critical patent/KR860003342A/ko
Application granted granted Critical
Publication of KR940009280B1 publication Critical patent/KR940009280B1/ko
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/006—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure
    • C07K9/008—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure directly attached to a hetero atom of the saccharide radical, e.g. actaplanin, avoparcin, ristomycin, vancomycin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/06—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using actinomycetales
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P5/00—Preparation of hydrocarbons or halogenated hydrocarbons
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/03—Actinomadura

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Mycology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Saccharide Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR1019850007474A 1984-10-11 1985-10-11 항생물질 A 40926 복합체 및 순수한 그의 인자 PA, PB, A, B 및 Bo의 제조방법 Expired - Lifetime KR940009280B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB8425685 1984-10-11
IT84-25685 1984-10-11
GB848425685A GB8425685D0 (en) 1984-10-11 1984-10-11 Antibiotic a 40926 complex

Publications (2)

Publication Number Publication Date
KR860003342A KR860003342A (ko) 1986-05-23
KR940009280B1 true KR940009280B1 (ko) 1994-10-06

Family

ID=10568022

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019850007474A Expired - Lifetime KR940009280B1 (ko) 1984-10-11 1985-10-11 항생물질 A 40926 복합체 및 순수한 그의 인자 PA, PB, A, B 및 Bo의 제조방법

Country Status (22)

Country Link
US (1) US4935238A (enExample)
EP (1) EP0177882B1 (enExample)
JP (2) JPH0637508B2 (enExample)
KR (1) KR940009280B1 (enExample)
AT (1) ATE49215T1 (enExample)
AU (1) AU599308B2 (enExample)
CA (1) CA1317900C (enExample)
DE (1) DE3575145D1 (enExample)
DK (1) DK161092C (enExample)
ES (1) ES8609352A1 (enExample)
FI (1) FI81117C (enExample)
GB (1) GB8425685D0 (enExample)
GR (1) GR852442B (enExample)
HU (1) HU194317B (enExample)
IE (1) IE58708B1 (enExample)
IL (1) IL76596A (enExample)
MY (1) MY100880A (enExample)
NO (1) NO164111C (enExample)
NZ (1) NZ213775A (enExample)
PH (1) PH23013A (enExample)
PT (1) PT81288B (enExample)
ZA (1) ZA857697B (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8531846D0 (en) * 1985-12-30 1986-02-05 Lepetit Spa Antibiotic a 40926 mannosyl aglycon
GB8608798D0 (en) * 1986-04-11 1986-05-14 Lepetit Spa Recovery of glycopeptide antibiotics from aqueous solutions
GB8608809D0 (en) * 1986-04-11 1986-05-14 Lepetit Spa Antibiotic
DK363587A (da) * 1986-07-30 1988-01-31 Smithkline Beckman Corp Antibiotika og fremstilling heraf under anvendelseaf actinomadura parvosata
GB8621912D0 (en) * 1986-09-11 1986-10-15 Lepetit Spa Increasing ratio of components of anti-biotic complex
GR871488B (en) * 1986-10-10 1987-11-12 Lepetit Spa New antibiotics
US5135857A (en) * 1987-07-03 1992-08-04 Gruppo Lepetit S.P.A. Process for the preparation of de-mannosyl teicoplanin derivatives
PH27266A (en) * 1989-03-14 1993-05-04 Fujisawa Pharmaceutical Co WS7622, A,B,C and D substances and pharmaceutical composition containing same
DE69117304T2 (de) * 1990-12-05 1996-08-29 Lepetit Spa 38-decarboxy-38-hydroxymethylderivate von teicoplaninantibiotika, und verfahren zu deren herstellung
KR100209971B1 (ko) 1991-03-27 1999-07-15 클라우디오 쿼르타 항생제 a 40926 에스테르 유도체
US5606036A (en) * 1991-03-27 1997-02-25 Gruppo Lepetit Spa Antibiotic A 40926 ester derivatives
US5750509A (en) * 1991-07-29 1998-05-12 Gruppo Lepetit S.P.A. Amide derivatives of antibiotic A 40926
DK0836619T3 (da) * 1995-07-05 2004-12-06 Aventis Bulk S P A Oprensning af dalbaheptid antibiotika ved hjælp af isoelektrisk fokusering
EP0912604B1 (en) 1996-04-23 2001-11-14 Biosearch Italia S.p.A. Improved chemical process for preparing amide derivatives of antibiotic A 40926
RU2124895C1 (ru) * 1998-05-28 1999-01-20 Головкина Любовь Павловна Противопаразитарная мазь "авермектиновая"
EP1413626A1 (en) * 2002-10-23 2004-04-28 Vicuron Pharmaceuticals, Inc. Genes and proteins for the biosynthesis of the glycopeptide antibiotic A40926
US20060074014A1 (en) 2002-11-18 2006-04-06 Vicuron Pharmaceuticals Inc. Dalbavancin compositions for treatment of bacterial infections
US7119061B2 (en) * 2002-11-18 2006-10-10 Vicuron Pharmaceuticals, Inc. Dalbavancin compositions for treatment of bacterial infections
US20050090433A1 (en) * 2002-11-18 2005-04-28 Vicuron Pharmaceuticals, Inc Dalbavancin compositions for treatment of bacterial infections
CN110183519B (zh) * 2019-05-06 2023-04-11 大邦(湖南)生物制药有限公司 一种达巴万星关键中间体a40926的分离纯化方法
CN110156876A (zh) * 2019-05-25 2019-08-23 聊城大学 一种适合工业化生产的高纯度a40926b0制备方法
US12545702B2 (en) * 2019-06-13 2026-02-10 Regeneron Pharmaceuticals, Inc. Methods for removing undesired components during multistage chromatographic processes
CN110940763B (zh) * 2019-12-19 2022-07-26 宜昌东阳光生化制药有限公司 分离纯化达巴万星前体a40926的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4195079A (en) * 1979-01-31 1980-03-25 Pfizer Inc. New polycyclic ether antibiotic
CA1183789A (en) * 1981-08-04 1985-03-12 Kiyoshi Isono Antibiotic 76-11, process for the production thereof, anticoccidiosis agent and domestic animals growth accelerator comprising the same as an effective ingredient
US4578271A (en) * 1982-05-24 1986-03-25 Fujisawa Pharmaceutical Co., Ltd. Biologically active WS 6049 substances, a process for the production thereof and their pharmaceutical compositions
GR78648B (enExample) * 1982-07-26 1984-09-27 Bristol Myers Co

Also Published As

Publication number Publication date
ATE49215T1 (de) 1990-01-15
EP0177882B1 (en) 1990-01-03
HU194317B (en) 1988-01-28
FI81117C (fi) 1990-09-10
JP2572937B2 (ja) 1997-01-16
NO854018L (no) 1986-04-14
IL76596A0 (en) 1986-02-28
KR860003342A (ko) 1986-05-23
ZA857697B (en) 1986-07-30
PT81288A (en) 1985-11-01
MY100880A (en) 1991-05-16
DK161092C (da) 1991-11-18
DK457385D0 (da) 1985-10-08
HUT39480A (en) 1986-09-29
IE58708B1 (en) 1993-11-03
PH23013A (en) 1989-03-03
NZ213775A (en) 1989-03-29
AU4819585A (en) 1986-04-17
US4935238A (en) 1990-06-19
EP0177882A3 (en) 1987-05-27
AU599308B2 (en) 1990-07-19
NO164111B (no) 1990-05-21
PT81288B (pt) 1987-10-20
CA1317900C (en) 1993-05-18
EP0177882A2 (en) 1986-04-16
FI853914A0 (fi) 1985-10-08
IL76596A (en) 1992-05-25
JPH0637508B2 (ja) 1994-05-18
DE3575145D1 (de) 1990-02-08
DK457385A (da) 1986-04-12
ES8609352A1 (es) 1986-09-01
ES547766A0 (es) 1986-09-01
FI81117B (fi) 1990-05-31
GR852442B (enExample) 1986-02-03
DK161092B (da) 1991-05-27
GB8425685D0 (en) 1984-11-14
IE852489L (en) 1986-04-11
FI853914L (fi) 1986-04-12
NO164111C (no) 1990-08-29
JPH06225757A (ja) 1994-08-16
JPS61148188A (ja) 1986-07-05

Similar Documents

Publication Publication Date Title
KR940009280B1 (ko) 항생물질 A 40926 복합체 및 순수한 그의 인자 PA, PB, A, B 및 Bo의 제조방법
EP0265071A1 (en) Glycopeptide antibiotics
KR960010556B1 (ko) 항생물질 a 40926 만노실 아글리콘
KR960010557B1 (ko) 항생물질 a 40926 n-아실아미노글루쿠로닐 아글리콘 및 항생물질 a 40926 아글리콘
KR960013074B1 (ko) 글리코펩티드 항생물질
JPH0123479B2 (enExample)
EP1285928B1 (en) Antibiotics tripropeptins and process for producing the same
EP0337731B1 (en) Peptide antibiotics
JPH0763387B2 (ja) テイコプラニン‐様誘導体
EP0254999A2 (en) Antibiotic A 42867 and the addition salts thereof
EP0318680A2 (en) Novel antibiotic compounds named A/16686 Factors A'1, A'2 and A'3
JPH0771479B2 (ja) 抗生物質ａ５１５６８因子ａおよびｂを産生する微生物
HUP0402383A2 (hu) GE 81112 A., B., B1 faktor antibiotikumok, gyógyászatilag elfogadható sóik és kompozícióik, valamint felhasználásuk
NZ227946A (en) Actinomadura strain atcc 39727 useful for producing antibiotic a 40926

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19851011

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 19901012

Comment text: Request for Examination of Application

Patent event code: PA02011R01I

Patent event date: 19851011

Comment text: Patent Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 19931130

Patent event code: PE09021S01D

G160 Decision to publish patent application
PG1605 Publication of application before grant of patent

Comment text: Decision on Publication of Application

Patent event code: PG16051S01I

Patent event date: 19940909

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 19950105

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 19950224

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 19950224

End annual number: 3

Start annual number: 1

PR1001 Payment of annual fee

Payment date: 19970924

Start annual number: 4

End annual number: 4

PR1001 Payment of annual fee

Payment date: 19980909

Start annual number: 5

End annual number: 5

PR1001 Payment of annual fee

Payment date: 19990927

Start annual number: 6

End annual number: 6

PR1001 Payment of annual fee

Payment date: 20000921

Start annual number: 7

End annual number: 7

PR1001 Payment of annual fee

Payment date: 20010918

Start annual number: 8

End annual number: 8

PR1001 Payment of annual fee

Payment date: 20020925

Start annual number: 9

End annual number: 9

PR1001 Payment of annual fee

Payment date: 20030924

Start annual number: 10

End annual number: 10

FPAY Annual fee payment

Payment date: 20041005

Year of fee payment: 11

PR1001 Payment of annual fee

Payment date: 20041005

Start annual number: 11

End annual number: 11

EXPY Expiration of term
PC1801 Expiration of term